Operating profit before amortization: biodesix.com (BDSX)

Public company logo of Biodesix (BDSX)

Expanded insurance coverage and integration into oncology centers are accelerating the growth of Biodesix, Inc. (BDSX). High physician confidence in AI-driven tests ensures the accuracy of non-invasive analysis. Monetization is based on B2B sales of diagnostic services to pulmonologists. This EBITDA_Co trend chart on GURU.Markets illustrates profit dynamics, where this metric equals 0.00, confirming the actual scale of the business.

BDSX Biodesix Corporation: Profit before payment of interest, taxes and amortization in the range 11/23/2025 - 11/12/2026

Summary analytical data breakdowns for Biodesix (BDSX)

- market price and analyst price targets:
Stock Price Biodesix Corporation|BDSX - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Biodesix|BDSX - Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Biodesix|BDSX - Company Book Value|Market Value to Book Value Ratio biodesix.com|BDSX - Cumulative Company Assets
- business debt structure and liquidity details:
Debt to Capital Biodesix, Inc.|BDSX - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Biodesix Inc|BDSX - Company Aggregate Debts|Debts to Net Assets Biodesix|BDSX - Company Long-Term Debt|Short-Term Debt Volume Biodesix|Quick Liquidity biodesix.com
- business earnings and investment ratios data:
BDSX - Net Profit|Company Profit Forecast Biodesix, Inc.|BDSX - Price to Earnings Ratio|Projected Price to Earnings Ratio biodesix.com|BDSX - PEG Multiple|Enterprise Value to Operating Income Before Depreciation Biodesix|BDSX - Operating profit EBITDA|Net earnings per one share for the last twelve months Biodesix|BDSX - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months biodesix.com|BDSX - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Biodesix, Inc.
Summary company analytics:BDSX Biodesix Corporation
Manufactured product of Biodesix Corp

This indicator captures actual cash flow from operating activities, excluding non-cash charges and tax adjustments to assess net production efficiency. Analyzing EBITDA allows for the tracking of revenue cyclicity, which for Biodesix, Inc. (BDSX) confirms steady cash flow growth driven by the broad clinical adoption of lung cancer molecular analysis systems.

Competitors of Biodesix, Inc. (BDSX)

Operating profit EBITDA Caris Corp CAI|GH - Profit before payment of interest, taxes and amortization|VCYT (veracyte.com) - Operating profit before amortization|CELC: Operating profit EBITDA|GRAIL Inc (GRAL) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Myriad Genetics Corp|Profit before payment of interest, taxes and amortization CSTL|Operating profit before deduction of amortization BNR (Burning Rock Biotech)|VNRX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Precipio PRPO|Operating income before deduction of amortization Check-Cap Ltd (CHEK)|Mainz Biomed - Operating profit EBITDA|Operating income before deduction of amortization OncoCyte Inc OCX